Several sessions at Psych Congress 2026 explore sleep symptoms in psychiatric illness, clinical considerations across the lifespan, and the role psychiatric clinicians can play in identifying and treating sleep-wake disorders.
Several sessions at Psych Congress 2026 explore sleep symptoms in psychiatric illness, clinical considerations across the lifespan, and the role psychiatric clinicians can play in identifying and treating sleep-wake disorders.
The US Food and Drug Administration (FDA) accepted Axsome Therapeutics’ New Drug Application (NDA) for AXS-12 (reboxetine) for cataplexy in narcolepsy.
The US Food and Drug Administration (FDA) accepted Axsome Therapeutics’ New Drug Application (NDA) for AXS-12 (reboxetine) for cataplexy in narcolepsy.
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression.
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression.
Experts highlighted the clinical and neurobiological overlap between sleep disturbances and psychiatric conditions at the 2026 NP Institute in Nashville.
Experts highlighted the clinical and neurobiological overlap between sleep disturbances and psychiatric conditions at the 2026 NP Institute in Nashville.
A narrative review in PLOS Mental Health synthesizes evidence on the bidirectional relationship between sleep and psychiatric disorders and highlights shared neurobiological mechanisms that span major depression, bipolar disorder (BD),...
A narrative review in PLOS Mental Health synthesizes evidence on the bidirectional relationship between sleep and psychiatric disorders and highlights shared neurobiological mechanisms that span major depression, bipolar disorder (BD),...
In an observational study, solriamfetol was found to reduce cognitive impairment associated with obstructive sleep apnea (OSA), independently of improvements in excessive daytime sleepiness (EDS)
In an observational study, solriamfetol was found to reduce cognitive impairment associated with obstructive sleep apnea (OSA), independently of improvements in excessive daytime sleepiness (EDS)
In patients with major depressive disorder with insomnia symptoms (MDDIS), response rates were similarly robust with adjunctive seltorexant and quetiapine extended-release (XR).
In patients with major depressive disorder with insomnia symptoms (MDDIS), response rates were similarly robust with adjunctive seltorexant and quetiapine extended-release (XR).
Compared with older adults without insomnia, older adults with the sleep disorder experienced a 3-fold greater increase in depressed mood and depressive symptoms after exposure to an inflammatory challenge, according to study findings.
Compared with older adults without insomnia, older adults with the sleep disorder experienced a 3-fold greater increase in depressed mood and depressive symptoms after exposure to an inflammatory challenge, according to study findings.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
The US Food and Drug Administration (FDA) accepted Axsome Therapeutics’ New Drug Application (NDA) for AXS-12 (reboxetine) for cataplexy in narcolepsy.
The US Food and Drug Administration (FDA) accepted Axsome Therapeutics’ New Drug Application (NDA) for AXS-12 (reboxetine) for cataplexy in narcolepsy.
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression.
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression.
A narrative review in PLOS Mental Health synthesizes evidence on the bidirectional relationship between sleep and psychiatric disorders and highlights shared neurobiological mechanisms that span major depression, bipolar disorder (BD),...
A narrative review in PLOS Mental Health synthesizes evidence on the bidirectional relationship between sleep and psychiatric disorders and highlights shared neurobiological mechanisms that span major depression, bipolar disorder (BD),...
Compared with older adults without insomnia, older adults with the sleep disorder experienced a 3-fold greater increase in depressed mood and depressive symptoms after exposure to an inflammatory challenge, according to study findings.
Compared with older adults without insomnia, older adults with the sleep disorder experienced a 3-fold greater increase in depressed mood and depressive symptoms after exposure to an inflammatory challenge, according to study findings.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
A new clinical practice guideline from the American Academy of Sleep Medicine recommends significant changes in the treatment of patients with restless leg syndrome (RLS), and updates the academy’s previous guidance from 2012.
A new clinical practice guideline from the American Academy of Sleep Medicine recommends significant changes in the treatment of patients with restless leg syndrome (RLS), and updates the academy’s previous guidance from 2012.
Older adults with sleep-related daytime dysfunction, consisting of excessive sleepiness and lower enthusiasm, are at increased risk of developing a predementia syndrome called motoric cognitive risk syndrome, according to a study published in...
Older adults with sleep-related daytime dysfunction, consisting of excessive sleepiness and lower enthusiasm, are at increased risk of developing a predementia syndrome called motoric cognitive risk syndrome, according to a study published in...
Results from a pilot study of patients with narcolepsy provide proof-of-concept evidence that a procedure called targeted lucidity reactivation can be adapted for narcolepsy-related nightmares.
Results from a pilot study of patients with narcolepsy provide proof-of-concept evidence that a procedure called targeted lucidity reactivation can be adapted for narcolepsy-related nightmares.
A self-led digital intervention targeting repetitive negative thinking significantly reduced anxiety during pregnancy and after childbirth, according to recent findings.
A self-led digital intervention targeting repetitive negative thinking significantly reduced anxiety during pregnancy and after childbirth, according to recent findings.
A single administration of mebufotenin benzoate nasal spray produced rapid, sustained reductions in depressive symptoms among adults with TRD, according to a phase 2b trial published in JAMA.
A single administration of mebufotenin benzoate nasal spray produced rapid, sustained reductions in depressive symptoms among adults with TRD, according to a phase 2b trial published in JAMA.
Investigational RAP-219 met the primary and secondary endpoints in a randomized, double-blind, placebo-controlled trial of adults experiencing acute bipolar mania, manufacturer Rapport Therapeutics announced on October 20, 2026.
Investigational RAP-219 met the primary and secondary endpoints in a randomized, double-blind, placebo-controlled trial of adults experiencing acute bipolar mania, manufacturer Rapport Therapeutics announced on October 20, 2026.
Home transcranial direct current stimulation paired with cognitive training delivered through a video game was feasible but offered no superior antidepressant benefit in a randomized clinical trial published in JAMA Network Open.
Home transcranial direct current stimulation paired with cognitive training delivered through a video game was feasible but offered no superior antidepressant benefit in a randomized clinical trial published in JAMA Network Open.
An individual participant data meta-analysis of 18 fixed-dose trials involving 7062 adults with acute schizophrenia found no evidence of sex differences in antipsychotic efficacy for overall symptom improvement.
An individual participant data meta-analysis of 18 fixed-dose trials involving 7062 adults with acute schizophrenia found no evidence of sex differences in antipsychotic efficacy for overall symptom improvement.
A connectivity-guided approach to accelerated iTBS produced greater short-term reductions in depression severity than conventional scalp-based targeting.
A connectivity-guided approach to accelerated iTBS produced greater short-term reductions in depression severity than conventional scalp-based targeting.
Young people beginning antipsychotic treatment after first-episode psychosis had low medication adherence, according to a retrospective US cohort study published in JAMA Network Open.
Young people beginning antipsychotic treatment after first-episode psychosis had low medication adherence, according to a retrospective US cohort study published in JAMA Network Open.
Reducing ultraprocessed food consumption was feasible and acceptable among adults with major depressive disorder (MDD) and was associated with lower depression and anxiety scores.
Reducing ultraprocessed food consumption was feasible and acceptable among adults with major depressive disorder (MDD) and was associated with lower depression and anxiety scores.
Vortioxetine was consistently associated with reduced depressive symptoms in older adults with MDD, while its effects on cognition were less consistent, according to a systematic review.
Vortioxetine was consistently associated with reduced depressive symptoms in older adults with MDD, while its effects on cognition were less consistent, according to a systematic review.
Semaglutide initiation was associated with fewer clinician-recorded cognitive signs and symptoms among adults with psychiatric disorders, according to a poster presented at Psych Congress.
Semaglutide initiation was associated with fewer clinician-recorded cognitive signs and symptoms among adults with psychiatric disorders, according to a poster presented at Psych Congress.
How to Use
Five items rated on 6-point Likert scale
Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use
Five items rated on 6-point Likert scale
Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
CBT-i Coach
Click image for app site
This app is the result of a collaborative effort between the US Department of Veterans Affairs’ National Center for PTSD, Stanford School of Medicine, and the US Department of Defense’s National...
CBT-i Coach
Click image for app site
This app is the result of a collaborative effort between the US Department of Veterans Affairs’ National Center for PTSD, Stanford School of Medicine, and the US Department of Defense’s National...
T2 Mood Tracker
Click image for app site
Originally developed as a tool for service members to easily record and review behavior changes particularly after combat deployments, it has now become very popular with many civilian users...
T2 Mood Tracker
Click image for app site
Originally developed as a tool for service members to easily record and review behavior changes particularly after combat deployments, it has now become very popular with many civilian users...
Click here for Medication Adherence Rating Scale (MARS) - page 7
The total score ranges from 0-10 with a higher score indicating better adherence
Strengths
Self-report...
Click here for Medication Adherence Rating Scale (MARS) - page 7
The total score ranges from 0-10 with a higher score indicating better adherence
Strengths
Self-report...
Click here for website for SDS
How to Use
The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.
How to Score
Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS
How to Use
The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.
How to Score
Total score 0-30 (0 unimpaired, 30 highly...
How to Use
The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale.
The BPRS is used as part of a clinical interview in which the clinician makes...
How to Use
The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale.
The BPRS is used as part of a clinical interview in which the clinician makes...
How to Use
The MINI is a widely used psychiatric structured diagnostic interview instrument.
To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.
The MINI...
How to Use
The MINI is a widely used psychiatric structured diagnostic interview instrument.
To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.
The MINI...
How to Use
The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.
Click here for the website for the MINI Screen
How to...
How to Use
The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.
Click here for the website for the MINI Screen
How to...
How to Use
The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use
The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use
Five items rated on 6-point Likert scale
Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use
Five items rated on 6-point Likert scale
Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use
The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.
The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use
The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.
The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
Click here for a PDF of the HAM-A
Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
Click here for a PDF of the HAM-A
Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
Arwen Podesta, MD, DFAPA, Psych Congress Steering Committee Member, and Mike Asbach, DMSc, PA-C, Co-Chair, Psych Congress PA Institute, discuss practical strategies for incorporating nutrition and exercise recommendations into psychiatric...
Arwen Podesta, MD, DFAPA, Psych Congress Steering Committee Member, and Mike Asbach, DMSc, PA-C, Co-Chair, Psych Congress PA Institute, discuss practical strategies for incorporating nutrition and exercise recommendations into psychiatric...
Kristian Dambrino, DNP, PMHNP-BC, explores the role that dual-mechanism and multimodal medications may play in individualized major depressive disorder (MDD) care.
Kristian Dambrino, DNP, PMHNP-BC, explores the role that dual-mechanism and multimodal medications may play in individualized major depressive disorder (MDD) care.
